560 related articles for article (PubMed ID: 27312520)
1. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
3. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
4. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
6. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
9. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables.
Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC
Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043
[TBL] [Abstract][Full Text] [Related]
12. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
14. Immunodetection of Epithelial-Mesenchymal Transition and Tumor Proliferation Markers in GLi-1-positive Oral Squamous Cell Carcinoma.
Dantas RCM; Guimarães VSN; de Souza RO; Valverde LF; Vidal MTA; Nogueira RLR; da Rocha LOS; Araújo GT; Dos Santos JN; Rocha CAG
Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):335-344. PubMed ID: 32769440
[TBL] [Abstract][Full Text] [Related]
15. A Correlative Study of N-Cadherin Expression with Different Grades of Oral Squamous Cell Carcinoma Projecting as a Marker of Epithelial to Mesenchymal Transition in Tumor Progression.
Rai K H; Ahmed J
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2327-2332. PubMed ID: 31450902
[TBL] [Abstract][Full Text] [Related]
16. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
Mahomed F; Altini M; Meer S
Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
[TBL] [Abstract][Full Text] [Related]
17. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin, β-catenin and Snail immunoexpression in laryngeal squamous cell carcinoma.
Cercelaru L; Stepan AE; Mărgăritescu C; Osman A; Popa IC; Florescu MM; Simionescu CE; Mărgăritescu OC
Rom J Morphol Embryol; 2017; 58(3):761-766. PubMed ID: 29250652
[TBL] [Abstract][Full Text] [Related]
19. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
20. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
